Step 6: Monitor and Evaluate Results

Monitoring and evaluation of programs to prevent and treat postpartum hemorrhage is critical for measuring progress towards expected results and to generate sound data to inform decisions made by policymakers and program implementers at all levels of the health system.

Conduct nationally representative household and facility surveys that include PPH-related indicators: Periodic national and/or sub-national household and facility surveys can help to document current clinical practices, such as PPH screening, counseling and management, raise awareness, and generate support for PPH programming. Facility surveys that POPPHI conducted in eight countries and MCHIP conducted in six countries identified areas of strength and areas for improvement in service quality. ICF Macro’s Service Provision Assessment (SPA) and WHO’s Service Availability Mapping (SAM) facility surveys collect information on health care provider training and drugs, supplies and equipment to detect and manage severe bleeding in pregnancy.7 The SPA also includes direct observation of ANC visits and ANC client exit interviews. ICF Macro’s Demographic and Health Surveys (DHS), conducted every five years, and UNICEF’s Multi-Indicator Cluster Surveys (MICS), conducted in select countries every two years, collect population-based data on ANC services received by pregnant women, including counseling about danger signs in pregnancy, specifically bleeding in pregnancy, anemia testing and receipt of iron tablets.

Integrate PPH-related indicators into the national government health sector M&E plan: Depending on the range and scale of PPH interventions, the national M&E plan can be developed to: assess PPH program baseline; identify key indicators to measure progress (outputs, outcomes and impact); and require review and strengthening of existing data collection systems. Revised global indicators to guide country health monitoring plans will be available in 2011 from a WHO-led maternal health indicators working group. An existing important resource that provides guidance on how to select and measure indicators related to antepartum and postpartum hemorrhage in the larger context of emergency obstetric care is WHO’s “Monitoring Emergency Obstetric Care: A Handbook,” published in 2009. Routine PPH-related data collection should be integrated into existing government health management information systems (HMIS) to the extent possible. Additional M&E requirements beyond those addressed through the HMIS will need to rely on national surveys, as described earlier, and special studies and monitoring efforts.

Ensure the national HMIS adequately captures PPH data, and the information is used for decision-making: Existing HMIS forms and reports at the community, facility and district levels may not be sufficient to track PPH-related data at home births attended by a skilled birth attendant and antenatal and delivery care at facilities. If the data are captured in the patient charts or registers, they still many not be aggregated and reported up to district/provincial/regional levels. And in areas with high levels of unattended home births, CHW-delivered services (such as misoprostol distribution) may not be reported into the HMIS at all. These data together are needed to monitor uterotonic coverage across a district/province/region, track stockouts, and recognize improvements over time.

Document and disseminate results: Complementing the M&E plan, a knowledge management (documentation) plan needs to be developed to ensure the PPH program will capture sufficient information from prevention and management activities to answer all key programmatic questions. Because programs often begin as small-scale pilots, lessons learned and cost-effectiveness information are desired, but not routinely collected as part of the M&E plan. To ensure results are monitored, documented and disseminated, a documentation plan can help country teams plan to comprehensively capture program process and outputs. Furthermore, qualitative case studies and success stories of women, families, CHWs and facility-based providers help illustrate the effect of these life-saving interventions on program beneficiaries. This plan can also include journal article submissions about innovative program approaches that are of interest to a wider audience.


Program Pitfalls and Lessons Learned: M&E

     Inclusion of a national-level indicator for AMTSL—or, at a minimum, the use of a uterotonic in the third stage of labor—in the HMIS requires providers and district and regional officials to report on its use on a regular basis, thus making it more likely to be routinely practiced and recorded.

     The POPPHI Project demonstrated that the use of national survey data can serve as a powerful advocacy tool, as these data can provide a base from which to develop strategic action plans, create partnerships, link allies, implement needed activities, and monitor progress toward goals.

     Stakeholders should be informed and involved throughout program implementation, monitoring progress and reviewing findings, especially during pilot studies on innovative interventions or approaches.

     Because the PPH prevention interventions are evidence-based, M&E can focus on program effectiveness in achieving coverage instead of measuring the reduction in mortality as a result. If there are sufficient resources, changes in mortality over time are powerful for advocating for scale-up.


2008 | Maternal and Child Health Integrated Program (MCHIP) | 4p
This compiled list includes output, outcome and impact indicators related to PPH prevention and management.
2007 | POPPHI | 29p
A set of simple qualitative research tools has been developed by POPPHI to help program planners better understand the attitudinal factors, barriers, and resistances to improved practice of AMTSL among both individual providers and obstetric teams. The tools also elicit information from a provider perspective on motivational factors and incentives to AMTSL use, and suggestions on how to effectively inform skilled attendants about the importance of AMTSL.

M&E Tools

Country Program Results

    2010 | ACCESS Program | 48p
    The purpose of this study was to demonstrate the safety, acceptability, feasibility, and program effectiveness (SAFE) of community-based distribution of misoprostol—an effective uterotonic drug—by Community Health Workers (CHWs) to reduce the incidence of PPH at home births in Afghanistan.
    2010 | Nepal Family Health Program | 4p
    Nepal Family Health Program (NFHP), the ACCESS Program with the Government of Nepal piloted a district-wide intervention to prevent PPH at home births through community-based distribution of misoprostol. This technical brief describes the intervention and findings.
    2008 | POPPHI
    A number of countries conducted assessments of the major barriers to use of AMTSL and provide descriptive information necessary to assess AMTSL practices. These assessments can be powerful tools for advocacy and to direct resources to address identified gaps. See the annotated bibliography for multi-country AMTSL assessment analysis (Stanton et al). More information, tools and resources are available on the POPPHI website (www.pphprevention.org)
    2008 | POPPHI | 59p
    This report describes use of the BD Uniject™ device1 prefilled with 10 international units (IU) of oxytocin for actively managing the third stage of labor in selected health centers in Mali. Although this single-dose, autodisable injection device has previously been used for tetanus toxoid vaccination in Mali, the Ministry of Health lacked documentation of the safety and feasibility of using the device to deliver oxytocin for AMTSL.
    2004 | MNH Program/Indonesia
    A study conducted by JHPIEGO’s Maternal and Neonatal Health (MNH) Program and its collaborators in Indonesia, with funding from USAID, offers evidence of the effectiveness of a community-based intervention to prevent postpartum hemorrhage (PPH). In the study, trained community volunteers provided women with information about prevention of PPH and the drug misoprostol (which controls bleeding following childbirth), distributed the medication to the women, and provided followup support.